Hims vs. Ro vs. Henry Meds for GLP-1 Weight Loss: 2026 Comparison

Medically reviewed by a licensed healthcare professional. Last updated March 2026.

Key Takeaways

• Hims, Ro, and Henry Meds are three of the most established telehealth platforms offering GLP-1 weight loss treatment in 2026.
• Pricing ranges from $149/month (Hims compounded) to $499+/month (Ro brand-name Wegovy).
• Each platform takes a different approach to medication options, clinical support, and program structure.
• Your best choice depends on whether you prioritize price, brand-name medication, or comprehensive support.

Quick Comparison

Hims Weight Loss Program

Hims entered the weight loss space as an extension of its established men's health and telehealth platform. The company has since expanded to serve all genders for weight management.

What's Included

• Initial medical consultation (asynchronous or video)
• Monthly or quarterly prescription for compounded semaglutide
• Provider check-ins at each dose escalation
• Mobile app for tracking progress
• Free home delivery with cold-chain shipping

Pricing

Hims offers compounded semaglutide starting at $199/month. Multi-month plans may offer savings — check current pricing on their platform. The price includes medication, consultations, and shipping with no hidden fees.

Strengths

• Well-established telehealth brand with millions of users
• Straightforward, transparent pricing
• User-friendly mobile app
• Fast turnaround on prescriptions (often 2-3 business days)

Limitations

• Does not offer brand-name Wegovy or Zepbound
• No insurance billing for weight loss program
• Clinical support is adequate but less intensive than specialized obesity programs
• Compounded medication is not FDA-approved

Ro (Body Program)

Ro has positioned itself as a more comprehensive clinical platform, offering both brand-name and compounded GLP-1 options through its Body Program.

What's Included

• Video or asynchronous provider consultations
• Choice of brand-name (Wegovy, Zepbound) or compounded GLP-1 medications
• Metabolic lab testing (mail-in kit)
• Body Program app with tracking tools
• Ongoing provider access for dose adjustments

Pricing

Ro's pricing varies based on medication choice:

• Compounded GLP-1: Starting at $149/month (membership model)
• Brand-name Wegovy/Zepbound: Market pricing, with insurance billing available for select plans

The membership model includes consultations and clinical support. Medication cost may be separate depending on your plan.

Strengths

• Offers both brand-name and compounded medications — one of the few platforms with both
• Insurance billing available for brand-name prescriptions
• Metabolic testing included for more personalized treatment
• Strong clinical infrastructure with experienced providers

Limitations

• Pricing structure can be confusing with separate membership and medication costs
• Brand-name medication through insurance requires prior authorization (can take weeks)
• Not available in all states for all medication types

Henry Meds

Henry Meds focuses specifically on weight loss and GLP-1 treatment, positioning itself as a specialized provider rather than a general telehealth platform.

What's Included

• Provider consultation (video or asynchronous)
• Monthly compounded semaglutide prescription
• Ongoing provider monitoring and dose adjustments
• Nutritional coaching and guidance
• Free priority shipping

Pricing

Henry Meds starts at $199/month, which bundles medication, consultations, and coaching. No separate membership fees or hidden costs.

Strengths

• Weight loss-focused platform with specialized providers
• Coaching and nutritional guidance included in base price
• Transparent all-inclusive pricing
• Good patient support and responsiveness

Limitations

• Compounded semaglutide only — no brand-name option
• Smaller platform with less brand recognition
• No insurance billing
• Fewer states covered than Hims or Ro

How to Choose: Decision Framework

Choose Hims if:

• You want a straightforward, well-known platform
• Compounded semaglutide fits your needs and budget
• You value a polished app experience and fast service
• You don't need insurance billing

Choose Ro if:

• You want the option of brand-name Wegovy or Zepbound
• Your insurance may cover GLP-1 medications
• You want metabolic testing as part of your program
• You value having the most medication options available

Choose Henry Meds if:

• You want coaching and nutritional guidance bundled in
• You prefer a weight loss-specialized provider
• All-inclusive pricing with no separate fees appeals to you
• You're comfortable with compounded medication

Important Considerations

Regardless of which provider you choose, keep these points in mind:

Compounded vs. brand-name matters. Compounded semaglutide is not FDA-approved and comes from compounding pharmacies with different quality oversight than brand-name manufacturers. If FDA-approved medication is important to you, Ro is the only platform of the three that offers it.

Provider quality varies. Ask about the credentials of your prescribing provider. Board-certified physicians and experienced nurse practitioners with weight management training will provide better care than newly licensed providers with limited obesity medicine experience.

Long-term commitment. GLP-1 treatment is not a short-term fix. Clinical evidence shows that weight regain is common after discontinuation ^[1]. Choose a provider you're comfortable working with for months or years.

Explore all your options on our telehealth provider comparison page or search for in-person GLP-1 clinics in your area.

---

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.

Sources

1. Wilding JPH, et al. "Weight Regain and Cardiometabolic Effects after Withdrawal of Semaglutide (STEP 1 Extension)." Diabetes, Obesity and Metabolism. 2022;24:1553-1564.
2. FDA. Wegovy Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf